Real-World Impact of Uncontrolled Symptoms and Suboptimal Treatment Response in Patients With Crohn’s Disease in the United States and Europe
Suboptimal treatment response was associated with increased symptoms and QoL burden. Despite the increased burden experienced, partial remitters were not more likely to switch or receive more treatment lines than remitters, demonstrating the need to initiate effective therapy.
Authors
- Sophie Barlow (ORCID: https://orcid.org/0000-0001-5604-1360)
- J Kershaw (ORCID: https://orcid.org/0000-0002-2086-7635)
- Cynthia Willey (ORCID: https://orcid.org/0000-0003-1966-7262)
- Myrlene Sanon Aigbogun (ORCID: https://orcid.org/0000-0003-4027-1254)
- Sumesh Kachroo (ORCID: https://orcid.org/0000-0002-7190-6323)
- Dominik Naessens
- Timothy Hoops
- Grace O’Neill (ORCID: https://orcid.org/0000-0001-9996-9994)
Institutions
- University of Rhode Island (US)
- Adelphi Group (United Kingdom) (GB)
- Janssen (United States) (US)
Publication Details
- Journal
- Crohn s & Colitis 360
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1093/crocol/otae074
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- United European Gastroenterology
- Janssen Biotech